These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 24544268

  • 1. 6-Diazo-5-oxo-L-norleucine, a new tumor-inhibitory substance. V. Microbiologic studies of mode of action.
    MAXWELL RE, NICKEL VS.
    Antibiot Chemother (Northfield); 1957 Feb; 7(2):81-9. PubMed ID: 24544268
    [No Abstract] [Full Text] [Related]

  • 2. A comparative study of 6-diazo-5-oxo-L-norleucine and O-diazoacety-L-serine on sarcoma 180.
    CLARKE DA, REILLY HC, STOCK CC.
    Antibiot Chemother (Northfield); 1957 Dec; 7(12):653-71. PubMed ID: 24544598
    [No Abstract] [Full Text] [Related]

  • 3. Potential anti-cancer agents--II. A proposed mechanism for the anti-cancer action of L-azaserine and 6-diazo-5-oxo-L-norleucine.
    BAKER BR.
    Biochem Pharmacol; 1959 Sep; 2():161-7. PubMed ID: 13795976
    [No Abstract] [Full Text] [Related]

  • 4. The effect of azaserine and 6-diazo-5-oxo-L-norleucine on the biosynthesis of inosinic acid de novo.
    BUCHANAN JM.
    Tex Rep Biol Med; 1957 Sep; 15(1):148-53. PubMed ID: 13409287
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of uric acid biosynthesis in birds by o-diazoacetyl-L-serine (azaserine) and 6-diazo-5-oxo-L-norleucine (DON).
    KRAKOFF IH, KARNOFSKY DA.
    Am J Physiol; 1958 Oct; 195(1):244-50. PubMed ID: 13583156
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of 6-diazo-5-oxo-L-norleucine on the incorporation of precursors into nucleic acids.
    BARCLAY RK, GARFINKEL E, PHILLIPPS MA.
    Cancer Res; 1962 Aug; 22():908-14. PubMed ID: 13864924
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Concentrative uptake of 6-diazo-5-oxo-L-norleucine by sarcoma 180, liver and muscle in vivo.
    JACQUEZ JA.
    Proc Soc Exp Biol Med; 1958 Dec; 99(3):611-3. PubMed ID: 13614439
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of 6 diazo 5 oxo l-norleucine on the rat litter in utero.
    THIERSCH JB.
    Proc Soc Exp Biol Med; 1957 Jan; 94(1):33-5. PubMed ID: 13400863
    [No Abstract] [Full Text] [Related]

  • 13. The effect of 6-diazo-5-oxo-1-norleucine (DON) on pregnancy.
    JACKSON D, ROBSON JM, WANDER AC.
    J Endocrinol; 1959 Mar; 18(2):204-7. PubMed ID: 13641559
    [No Abstract] [Full Text] [Related]

  • 14. Alterations in calcium metabolism in cancer patients treated with 6-diazo-5-oxo-L-norleucine.
    MAGILL GB, MYERS WP.
    Proc Soc Exp Biol Med; 1956 Nov; 93(2):314-8. PubMed ID: 13379496
    [No Abstract] [Full Text] [Related]

  • 15. Chromatographic studies of purine metabolism. V. Inhibition mechanism of diazo-oxo-norleucine in wild-type and in diazo-oxo-norleucine-resistant Escherichia coli.
    TOMISEK AJ, REID MR.
    J Biol Chem; 1962 Mar; 237():807-11. PubMed ID: 13921756
    [No Abstract] [Full Text] [Related]

  • 16. Suppression of uric acid synthesis in the gouty human by the use of 6-diazo-5-oxo-L-norleucine.
    GRAYZEL AI, SEEGMILLER JE, LOVE E.
    J Clin Invest; 1960 Mar; 39(3):447-54. PubMed ID: 13829149
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of 6-diazo-5-oxo-L-norleucine and N-[N-gamma-glutamyl-6-diazo-5-oxo-norleucinyl]-6-diazo-5-oxo-norleucine against experimental tumors in conventional and nude mice.
    Ovejera AA, Houchens DP, Catane R, Sheridan MA, Muggia FM.
    Cancer Res; 1979 Aug; 39(8):3220-4. PubMed ID: 572261
    [Abstract] [Full Text] [Related]

  • 18. 6-DIAZO-5-OXO-L-NORLEUCINE INHIBITION OF ESCHERICHIA COLI.
    COGGIN JH, MARTIN WR.
    J Bacteriol; 1965 May; 89(5):1348-53. PubMed ID: 14293024
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological and initial therapeutic observations on 6-diazo-5-oxo-1-norleucine (DON) in human neoplastic disease.
    MAGILL GB, MYERS WP, REILLY HC, PUTNAM RC, MAGILL JW, SYKES MP, ESCHER GC, KARNOFSKY DA, BURCHENAL JH.
    Cancer; 1957 May; 10(6):1138-50. PubMed ID: 13489662
    [No Abstract] [Full Text] [Related]

  • 20. [Inactivation of microbial glutamin-(asparagin-)ase by azaserine and 6-diazo-5-oxo-L-norleucine].
    Lebedeva ZI, Kabanova EA, Berezov TT.
    Biull Eksp Biol Med; 1985 Dec; 100(12):696-8. PubMed ID: 4074870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.